|
| Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cells |
|
https://doi.org/10.18632/oncotarget.27539
Lacey M. Litchfield, Karsten Boehnke, Manisha Brahmachary, Cecilia Mur, Chen Bi, Jennifer R. Stephens, J. Michael Sauder, Sonia M. Gutiérrez, Ann M. McNulty, Xiang S. Ye, Wenjuan Wu, María José Lallena, Xueqian Gong, Farhana F. Merzoug, Valerie M. Jansen, Sean G. Buchanan
|
| 1478-1492 |
|
| Lactate induces PD-L1 in HRASG12V-positive oropharyngeal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.27348
Alexander K. Verma, Shanta M. Messerli, W. Keith Miskimins
|
| 1493-1504 |
|
| CrkL is required for donor T cell migration to GvHD target organs |
|
https://doi.org/10.18632/oncotarget.27509
Nathan H. Roy, Mahinbanu Mammadli, Janis K. Burkhardt, Mobin Karimi
|
| 1505-1514 |
|
| Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patients |
|
https://doi.org/10.18632/oncotarget.27566
Tali Sinai-Livne, Metsada Pasmanik-Chor, Zoya Cohen, Ilan Tsarfaty, Haim Werner, Raanan Berger
|
| 1515-1530 |
|
| The cytotoxicity of gallium maltolate in glioblastoma cells is enhanced by metformin through combined action on mitochondrial complex 1 |
|
https://doi.org/10.18632/oncotarget.27567
Hisham S. Alhajala, John L. Markley, Jin Hae Kim, Mona M. Al-Gizawiy, Kathleen M. Schmainda, John S. Kuo, Christopher R. Chitambar
|
| 1531-1544 |
|
| CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? |
|
https://doi.org/10.18632/oncotarget.27568
Valentina Masciale, Giulia Grisendi, Federico Banchelli, Roberto D’Amico, Antonino Maiorana, Pamela Sighinolfi, Alessandro Stefani, Uliano Morandi, Massimo Dominici, Beatrice Aramini
|
| 1545-1555 |
|
| Lack of CD8+ T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors |
|
https://doi.org/10.18632/oncotarget.27569
Salum J. Lidenge, For Yue Tso, Owen Ngalamika, Jaydeep Kolape, John R. Ngowi, Julius Mwaiselage, Charles Wood, John T. West
|
| 1556-1572 |
|
| Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model |
|
https://doi.org/10.18632/oncotarget.27476
Gerben R. Borst, Ramya Kumareswaran, Hatice Yücel, Seyda Telli, Trevor Do, Trevor McKee, Gaetano Zafarana, Jos Jonkers, Marcel Verheij, Mark J. O’Connor, Sven Rottenberg, Robert G. Bristow
|
| 1573-1574 |
|
| Correction: Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation |
|
https://doi.org/10.18632/oncotarget.27542
Shao-Qian Sun, Xiaobin Gu, Xian-Shu Gao, Yi Li, Hongliang Yu, Wei Xiong, Hao Yu, Wen Wang, Yingbo Li, Yingqi Teng, Demin Zhou
|
| 1575-1575 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
